Bristol-Myers Squibb Company (BMY)
Operating return on assets (Operating ROA)
Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating income (ttm) | US$ in thousands | -9,504,000 | -10,337,000 | -10,597,000 | -9,851,000 | -10,280,000 | -12,331,000 | -12,539,000 | -14,016,000 | -15,487,000 | -1,800,000 | -2,410,000 | -3,043,000 | -3,317,000 | -6,022,000 | 1,007,000 | 4,789,000 | 8,778,000 | 7,608,000 | 4,642,000 | 4,075,000 |
Total assets | US$ in thousands | 95,159,000 | 91,263,000 | 93,489,000 | 94,281,000 | 96,820,000 | 98,196,000 | 100,357,000 | 103,034,000 | 109,314,000 | 110,893,000 | 110,797,000 | 112,435,000 | 118,481,000 | 125,536,000 | 128,076,000 | 129,285,000 | 129,944,000 | 57,433,000 | 55,163,000 | 34,834,000 |
Operating ROA | -9.99% | -11.33% | -11.34% | -10.45% | -10.62% | -12.56% | -12.49% | -13.60% | -14.17% | -1.62% | -2.18% | -2.71% | -2.80% | -4.80% | 0.79% | 3.70% | 6.76% | 13.25% | 8.42% | 11.70% |
December 31, 2023 calculation
Operating ROA = Operating income (ttm) ÷ Total assets
= $-9,504,000K ÷ $95,159,000K
= -9.99%
Operating return on assets (Operating ROA) is a key financial ratio that indicates how efficiently a company generates profits from its assets used in operations. In the case of Bristol-Myers Squibb Co., the operating ROA has been relatively stable and healthy over the past eight quarters.
The operating ROA for Q4 2023 was 8.61%, a slight decrease compared to the previous quarter's 8.69%. However, the company's performance in Q4 2023 remained consistent with the previous year's performance in the same quarter, where the operating ROA was also 9.40%.
Looking at the trend over the past eight quarters, Bristol-Myers Squibb Co. has generally maintained an operating ROA above 8%, with the highest point at 9.84% in Q3 2022. The company's operating ROA dipped to 7.98% in Q1 2022 but has shown improvement since then.
Overall, the consistent performance of Bristol-Myers Squibb Co. in generating operating profits from its assets indicates efficient asset utilization and operational effectiveness. Investors and stakeholders may view the company favorably for its ability to generate returns from the assets deployed in its operations.
Peer comparison
Dec 31, 2023